My understanding is that Biogene will be adopting a licence fee/royalty revenue model whereby they will sell the rights to their patented technology to big agrichem/pesticide multinationals. Accordingly price competition should not be an issue for Biogene. Pricing will be in the hands of the multi-nationals who will set the price based on blended outcomes. In other words flavorcide and qcide will be blended with existing herbicides, insecticides and other solutions in various formula to maximise its application.
Hope this helps but stand to be corrected.
My understanding is that Biogene will be adopting a licence...
Add BGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105390 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 35000 | 1 |
View Market Depth
| Last trade - 09.59am 02/05/2024 (20 minute delay) ? |
| BGT (ASX) Chart |
Day chart unavailable